Literature DB >> 19289856

Exclusive expression of proteasome subunit {beta}5t in the human thymic cortex.

Utano Tomaru1, Akihiro Ishizu, Shigeo Murata, Yukiko Miyatake, Sayuri Suzuki, Satomi Takahashi, Taku Kazamaki, Jiro Ohara, Tomohisa Baba, Sari Iwasaki, Kazunori Fugo, Noriyuki Otsuka, Keiji Tanaka, Masanori Kasahara.   

Abstract

The ubiquitin-proteasome pathway, which degrades intracellular proteins, is involved in numerous cellular processes, including the supply of immunocompetent peptides to the antigen presenting machinery. Proteolysis by proteasomes is conducted by three beta subunits, beta1, beta2, and beta5, of the 20S proteasome. Recently, a novel beta subunit expressed exclusively in cortical thymic epithelial cells was discovered in mice. This subunit, designated beta5t, is a component of the thymoproteasome, a specialized type of proteasomes implicated in thymic positive selection. In this study, we show that, like its mouse counterpart, human beta5t is expressed exclusively in the thymic cortex. Human beta5t was expressed in approximately 80% of cortical thymic epithelial cells and some cortical dendritic cells. Human beta5t was incorporated into proteasomes with two other catalytically active beta subunits beta1i and beta2i, forming 20S proteasomes with subunit compositions characteristic of thymoproteasomes. The present study demonstrates, for the first time, the existence of thymoproteasomes in the human thymic cortex, indicating that thymoproteasome function is likely conserved between humans and mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289856     DOI: 10.1182/blood-2008-11-187633

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

Review 1.  Aging and immune function: molecular mechanisms to interventions.

Authors:  Subramaniam Ponnappan; Usha Ponnappan
Journal:  Antioxid Redox Signal       Date:  2011-01-08       Impact factor: 8.401

Review 2.  Thymic stromal cell subsets for T cell development.

Authors:  Takeshi Nitta; Harumi Suzuki
Journal:  Cell Mol Life Sci       Date:  2016-01-29       Impact factor: 9.261

Review 3.  Proteasomes in immune cells: more than peptide producers?

Authors:  Marcus Groettrup; Christopher J Kirk; Michael Basler
Journal:  Nat Rev Immunol       Date:  2009-12-11       Impact factor: 53.106

Review 4.  Thymoproteasome and peptidic self.

Authors:  Yousuke Takahama; Izumi Ohigashi; Shigeo Murata; Keiji Tanaka
Journal:  Immunogenetics       Date:  2018-10-15       Impact factor: 2.846

Review 5.  Thymus machinery for T-cell selection.

Authors:  Kenta Kondo; Izumi Ohigashi; Yousuke Takahama
Journal:  Int Immunol       Date:  2019-03-05       Impact factor: 4.823

Review 6.  Origin and evolution of the specialized forms of proteasomes involved in antigen presentation.

Authors:  Masanori Kasahara; Martin F Flajnik
Journal:  Immunogenetics       Date:  2019-01-24       Impact factor: 2.846

Review 7.  Peptide splicing by the proteasome.

Authors:  Nathalie Vigneron; Violette Ferrari; Vincent Stroobant; Joanna Abi Habib; Benoit J Van den Eynde
Journal:  J Biol Chem       Date:  2017-11-06       Impact factor: 5.157

8.  Comparative genomic analysis of the proteasome β5t subunit gene: implications for the origin and evolution of thymoproteasomes.

Authors:  Yoichi Sutoh; Mizuho Kondo; Yuko Ohta; Tatsuya Ota; Utano Tomaru; Martin F Flajnik; Masanori Kasahara
Journal:  Immunogenetics       Date:  2011-07-07       Impact factor: 2.846

9.  A human PSMB11 variant affects thymoproteasome processing and CD8+ T cell production.

Authors:  Izumi Ohigashi; Yuki Ohte; Kazuya Setoh; Hiroshi Nakase; Akiko Maekawa; Hiroshi Kiyonari; Yoko Hamazaki; Miho Sekai; Tetsuo Sudo; Yasuharu Tabara; Hiromi Sawai; Yosuke Omae; Rika Yuliwulandari; Yasuhito Tanaka; Masashi Mizokami; Hiroshi Inoue; Masanori Kasahara; Nagahiro Minato; Katsushi Tokunaga; Keiji Tanaka; Fumihiko Matsuda; Shigeo Murata; Yousuke Takahama
Journal:  JCI Insight       Date:  2017-05-18

Review 10.  Present Yourself! By MHC Class I and MHC Class II Molecules.

Authors:  Kenneth L Rock; Eric Reits; Jacques Neefjes
Journal:  Trends Immunol       Date:  2016-09-07       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.